William B. Horne - 08 Sep 2021 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director
Signature
/s/ William B. Horne
Issuer symbol
ALZN
Transactions as of
08 Sep 2021
Net transactions value
$0
Form type
4
Filing time
10 Sep 2021, 17:00:31 UTC
Previous filing
24 Aug 2021
Next filing
12 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Options Exercise $0 +100,000 $0.000000 100,000 08 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Stock Options (Right to Buy) Options Exercise $0 -100,000 -4% $0.000000 2,400,000 08 Sep 2021 Common Stock 100,000 $0.004000 Direct F2
holding ALZN Stock Options (Right to Buy) 250,000 08 Sep 2021 Common Stock 250,000 $1.50 Direct F3
holding ALZN Stock Options (Right to Buy) 250,000 08 Sep 2021 Common Stock 250,000 $1.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to Rule 16b-3 with shares of common stock received upon the exercise of stock options.
F2 The stock options exercised in this transaction were fully vested and exercisable as of the transaction date.
F3 The stock options vest ratably over thirty-six (36) months beginning on the date of grant.
F4 None of these performance-based stock options are vested or exercisable.